Cargando…

A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis

OBJECTIVE: Endometrial cancer recurrence is one of the main factors leading to increased mortality, and there is a lack of predictive models. Our study aimed to establish a nomogram predictive model to predict recurrence in endometrial cancer patients. METHOD: Screen 517 endometrial cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Mengdan, Zhu, Yanping, Wang, Lulu, Miao, Yifei, Li, Rong, Zhou, Huaijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661936/
https://www.ncbi.nlm.nih.gov/pubmed/38027107
http://dx.doi.org/10.3389/fendo.2023.1156169
_version_ 1785138093228032000
author Miao, Mengdan
Zhu, Yanping
Wang, Lulu
Miao, Yifei
Li, Rong
Zhou, Huaijun
author_facet Miao, Mengdan
Zhu, Yanping
Wang, Lulu
Miao, Yifei
Li, Rong
Zhou, Huaijun
author_sort Miao, Mengdan
collection PubMed
description OBJECTIVE: Endometrial cancer recurrence is one of the main factors leading to increased mortality, and there is a lack of predictive models. Our study aimed to establish a nomogram predictive model to predict recurrence in endometrial cancer patients. METHOD: Screen 517 endometrial cancer patients who came to Nanjing Drum Tower Hospital from 2008 to 2018. All these data are listed as the training group, and then 70% and 60% are randomly divided into verification groups 1 and 2. Univariate, Multivariate logistic regression, stepwise regression were used to select variables for nomogram. Nomogram identification and calibration were evaluated by concordance index (c-index), area under receiver operating characteristic curve (AUC) over time and calibration plot Function. By decision curve analysis (DCA), net reclassification index (NRI), integrated discrimination improvement (IDI), we compared and quantified the net benefit of nomogram and ESMO-ESGO-ESTRO model-based prediction of tumor recurrence. RESULTS: A nomogram predictive model of endometrial cancer recurrence was established with the eight variables screened. The c-index (for the training cohort and for the validation cohort) and the time-dependent AUC showed good discriminative power of the nomogram. Calibration plots showed good agreement between nomogram predictions and actual observations in both the training and validation sets. CONCLUSIONS: We developed and validated a predictive model of endometrial cancer recurrence to assist clinicians in assessing recurrence in endometrial cancer patients.
format Online
Article
Text
id pubmed-10661936
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106619362023-01-01 A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis Miao, Mengdan Zhu, Yanping Wang, Lulu Miao, Yifei Li, Rong Zhou, Huaijun Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Endometrial cancer recurrence is one of the main factors leading to increased mortality, and there is a lack of predictive models. Our study aimed to establish a nomogram predictive model to predict recurrence in endometrial cancer patients. METHOD: Screen 517 endometrial cancer patients who came to Nanjing Drum Tower Hospital from 2008 to 2018. All these data are listed as the training group, and then 70% and 60% are randomly divided into verification groups 1 and 2. Univariate, Multivariate logistic regression, stepwise regression were used to select variables for nomogram. Nomogram identification and calibration were evaluated by concordance index (c-index), area under receiver operating characteristic curve (AUC) over time and calibration plot Function. By decision curve analysis (DCA), net reclassification index (NRI), integrated discrimination improvement (IDI), we compared and quantified the net benefit of nomogram and ESMO-ESGO-ESTRO model-based prediction of tumor recurrence. RESULTS: A nomogram predictive model of endometrial cancer recurrence was established with the eight variables screened. The c-index (for the training cohort and for the validation cohort) and the time-dependent AUC showed good discriminative power of the nomogram. Calibration plots showed good agreement between nomogram predictions and actual observations in both the training and validation sets. CONCLUSIONS: We developed and validated a predictive model of endometrial cancer recurrence to assist clinicians in assessing recurrence in endometrial cancer patients. Frontiers Media S.A. 2023-11-07 /pmc/articles/PMC10661936/ /pubmed/38027107 http://dx.doi.org/10.3389/fendo.2023.1156169 Text en Copyright © 2023 Miao, Zhu, Wang, Miao, Li and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Miao, Mengdan
Zhu, Yanping
Wang, Lulu
Miao, Yifei
Li, Rong
Zhou, Huaijun
A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
title A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
title_full A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
title_fullStr A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
title_full_unstemmed A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
title_short A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
title_sort nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661936/
https://www.ncbi.nlm.nih.gov/pubmed/38027107
http://dx.doi.org/10.3389/fendo.2023.1156169
work_keys_str_mv AT miaomengdan anomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT zhuyanping anomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT wanglulu anomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT miaoyifei anomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT lirong anomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT zhouhuaijun anomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT miaomengdan nomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT zhuyanping nomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT wanglulu nomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT miaoyifei nomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT lirong nomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis
AT zhouhuaijun nomogramforpredictingrecurrenceinendometrialcancerpatientsapopulationbasedanalysis